sermorelin research peptide
Sales!

Sermorelin

$75.00

In Stock
Sermorelin is a growth hormone–releasing hormone (GHRH) analog studied for its ability to stimulate endogenous growth hormone secretion. By activating the pituitary gland, it may support natural hormonal production without directly introducing exogenous growth hormone. Research focuses on its applications in hormonal balance and metabolic support.

In stock

Quantity Discount (%) Price
1 $75.00
2 41.33 % $44.00
5 42.67 % $43.00
8+ 46.67 % $40.00

99%+ Purity Tests

Ships from USA

USA Lab Tested

Free bacteriostatic water with every order.

Overview

Research indicates that Sermorelin may help stimulate the body’s natural growth hormone production by mimicking growth hormone-releasing hormone. Studies suggest this synthetic peptide could support lean muscle development, improve skin thickness, and promote cardiovascular health by aiding heart cell function. Early research also points to potential benefits for insulin sensitivity and overall metabolic health. As a growth hormone secretagogue, it works by activating the pituitary gland rather than directly supplying hormones, offering a more natural approach to supporting healthy aging. For an in-depth look at research and laboratory applications, see our Sermorelin research guide.

Key Characteristics

Molecular Details

  • Chemical Name: L-Carnitine (levocarnitine)

  • Chemical Formula: C₇H₁₅NO₃

  • Molecular Weight: 161.20 g/mol

  • CAS Number: 541-15-1

  • Structure: Quaternary ammonium compound naturally synthesized from lysine and methionine and essential for fatty acid transport

Product Information

  • Form: Lyophilized peptide powder

  • Solubility: Soluble in sterile water or compatible buffer prior to use

  • Stability: Stable under refrigerated storage; limited stability after reconstitution

  • Half-Life: Short biologic half-life (~10–30 minutes)

  • Storage: Store refrigerated at 36–46°F (2–8°C); protect from light and moisture

How It Works

A synthetic growth hormone–releasing hormone (GHRH 1-29) analog researched for its ability to stimulate natural growth hormone production and support endocrine signaling pathways.

Primary Mechanisms

GHRH Receptor Stimulation

Binds to anterior pituitary GHRH receptors to trigger pulsatile growth hormone release

IGF-1 Modulation

Promotes downstream insulin-like growth factor 1 production through endogenous GH signaling

Physiologic GH Pulsatility Support

Encourages natural secretion patterns rather than exogenous hormone replacement

Anabolic Signaling Activation

Influences protein synthesis and tissue repair pathways in research models

Research Benefits

Endogenous Growth Hormone Support

Studied for increasing natural GH levels in controlled models

Body Composition Research

Explored for effects on lean mass preservation and adipose tissue modulation

Sleep & Recovery Pathways

Investigated for influence on restorative and regenerative signaling

Research Findings

Laboratory investigations have provided valuable insights into CJC-1295’s biological activity and research applications.

Growth Hormone & IGF-1 Response

Studies demonstrate:

  • Increased GH pulsatility in research subjects

  • Secondary elevation of IGF-1 levels

  • Enhanced GH secretory patterns without exogenous GH administration

Body Composition Effects

Research indicates:

  • Improved lean mass markers in some models

  • Reduced fat mass relative to baseline

  • Supports improvements in body composition

Metabolic & Tissue Effects

    • Enhanced protein synthesis signaling

    • Improved connective tissue repair markers

    • Support for anabolic processes in musculoskeletal models

Endocrine Observations

Research shows:

  • Maintained natural GH rhythm with pulsatile stimulation

  • Favorable endocrine profile with minimal suppression of endogenous axis

  • Safe receptor engagement in controlled research settings

Potential Side Effects in Research

Safety considerations and tolerability profile observed in research settings.

Generally Well Tolerated

Observed effects appear dose-dependent and transient.

Common Observations

Mild flushing, temporary lightheadedness, injection site irriatation

Hormonal Adjustments

Transient metabolic shifts associated with GH elevation

Monitoring Recommended

IGF-1 levels, fasting glucose, endocrine panel markers

Oral dosing individualized based on research design.

References

THIRD-PARTY LAB TESTED

Certificate of Analysis

Independent laboratory testing confirms purity and composition

99.453%

Purity

32ABF

Batch

January 2026

Date

Related products

Select options This product has multiple variants. The options may be chosen on the product page
Select options This product has multiple variants. The options may be chosen on the product page